In response to this matter, the reporter contacted the relevant person in charge of Yiling Pharmaceutical. It said that Yiling Pharmaceutical has been doing a series of work to improve production capacity in the past two years, and the current production capacity has been greatly improved; The company's production plan is "fixed production by sales", which can be adjusted in time according to market demand to ensure market supply; The company's production is basically unaffected, and the current sales situation is all normal. As for the need to queue up to buy in the company, it is because the internal purchase has changed from the original traditional self-delivery to online express delivery, and the time is longer than the self-delivery.
You can also buy it online.
Recently, the Comprehensive Group of the Joint Prevention and Control Mechanism of novel coronavirus, the State Council issued the Notice on Further Optimizing the Prevention and Control Measures of COVID-19's Epidemic, and doing a good job in prevention and control scientifically and accurately, requesting to speed up the storage of drugs related to COVID-19's treatment. Pay attention to the unique advantages of traditional Chinese medicine and make a good reserve of effective traditional Chinese medicine prescriptions.
According to the guidance of novel coronavirus's Diagnosis and Treatment Plan (Trial Ninth Edition), it is suggested that Jinhua Qinggan Granules, Lianhua Qingwen Capsules (granules) and Shufeng Jiedu Capsules (granules) should be used in the treatment of traditional Chinese medicine in COVID-19. It is also recommended to take Lianhua Qingwen capsules (granules), which are divided into mild and ordinary types.
It is understood that at present, most patients and pharmacies in the market are dispensing drugs according to the drug guidance of the Trial Ninth Edition, which has led to the phenomenon of selling out of stock in some areas in a short time.
The reporter learned from online shopping channels such as Meituan Pharmacy and Ali Pharmacy that Lianhua Qingyi Capsule and Lianhua Qingyi Granule have really sold well recently. Lianhua Qingwen Capsule of Yiling Pharmaceutical (0.35g*24 capsules/box), Meituan's self-operated pharmacy sold 38,000 orders in the past month, and the flagship store of Taobao Yiling Yaotang pharmacy sold more than 20,000 orders every month.
However, Lianhua Qingyi products on these online shopping platforms are not out of stock. Meituan's trading APP shows that most pharmacies and Meituan's self-operated pharmacies can deliver goods within 24 hours.
In some areas, because of the epidemic prevention and control requirements, online shopping is impossible. For example, the flagship store of Yiling drugstore in Taobao shows that it is temporarily impossible to place an order in Guangzhou and Shenzhen, but if the receiving address is changed to Shantou and Zhongshan in Guangdong Province, the order can be placed smoothly.
Image from Taobao screenshot
From this point of view, the phenomenon that Lianhua Qingwen series products are robbed and out of stock on the Internet is not nationwide, but may be only a short-term shortage in some areas.
The production capacity has been greatly improved.
Yiling Pharmaceutical's main business is the research and development, production and sales of patented innovative Chinese medicine. The series of Lianhua Qingwen products produced and sold by Yiling Pharmaceutical Co., Ltd. have attracted much attention because they have entered the diagnosis and treatment projects in COVID-19 for many times.
In the past two years, Lianhua Qingwen products have been rumored to be out of stock many times, and Yiling Pharmaceutical has repeatedly clarified that the production capacity is sufficient and there is no need to panic.
In response to the rumors of selling out of stock, the relevant person in charge of Yiling Pharmaceutical told reporters that Yiling Pharmaceutical has been doing a series of work to improve production capacity in the past two years. At present, its production capacity has been greatly improved. Shijiazhuang, Beijing, Hengshui and other places have factories that produce Lianhua Qingyi products, and the current production has basically not been affected.
He also said that the production plan of Yiling Pharmaceutical is "fixed production by sales", which can be adjusted in time according to market demand to ensure market supply. Everything is normal in sales at present.
Up to now, Yiling Pharmaceutical has not publicly disclosed the specific sales situation of Lianhua Qingwen. Not long ago, Yiling Pharmaceutical mentioned in the record of investor relations activities that in the first three quarters of this year, the sales revenue of the company's formula granule business increased well year-on-year.
This year's semi-annual report shows that the market share of Lianhua Qingwen products of Yiling Pharmaceutical is increasing year by year. 20 17 by the first half of 2022, Lianhua's market share of temperature-clearing products increased from 2.44% to 9.37%, ranking first.
Want to know more financial news in real time, please pay attention to us.